S 4601·NJ·senate
Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.
Passed One ChamberFiled Sep 28, 2026
Sponsor: Joe Vitale (D)
Latest Action
Passed Senate (39-0)
Oct 22, 2026
Summary
The bill would obligate any pharmacist—or a person they designate—to inform a consumer if the medication they receive is a substitute for the drug or biological product originally prescribed. It aims to increase transparency for patients about what they are taking and why a substitution was made.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when S 4601 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4601 freeOr ask your AI assistant about S 4601 directly:
Add to Claude, ChatGPT or Cursor